Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀüÀ̼º Àü¸³¼±¾ÏÀ¸·Î ÀÎÇØ ¹ß»ýÇÑ Ã´¼ö¾Ð¹Ú ȯÀÚÀÇ ÀÓ»óÀû Ư¼º ºÐ¼® Analysis of the Clinical Features of Patients with Metastatic Spinal Cord Compression Caused by Prostate Cancer

´ëÇѺñ´¢±â°úÇÐȸÁö 2009³â 50±Ç 12È£ p.1174 ~ 1181
È«¼º¿ì, À¯´Þ»ê, È«ÁØÇõ, ±èû¼ö, ¾ÈÇÑÁ¾, Á¤Àΰ©,
¼Ò¼Ó »ó¼¼Á¤º¸
È«¼º¿ì ( Hong Sung-Woo ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ºñ´¢±â°úÇб³½Ç

À¯´Þ»ê ( You Dal-San ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ºñ´¢±â°úÇб³½Ç
È«ÁØÇõ ( Hong Jun-Hyuk ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ºñ´¢±â°úÇб³½Ç
±èû¼ö ( Kim Choung-Soo ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ºñ´¢±â°úÇб³½Ç
¾ÈÇÑÁ¾ ( Ahn Han-Jong ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ºñ´¢±â°úÇб³½Ç
Á¤Àΰ© ( Jeong In-Gab ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ºñ´¢±â°úÇб³½Ç

Abstract


Purpose: The purpose of this study was to investigate the clinical presentation and outcomes of metastatic spinal cord compression (MSCC) caused by prostate cancer (PCa) and to determine the prognostic factors for relieving the symptoms of MSCC.

Materials and Methods: A total of 52 patients (47 who underwent radiotherapy and 5 who underwent surgery) treated between 1989 and 2007 were included. We investigated potential prognostic factors for the improvement of symptoms caused by MSCC. Multivariate Cox proportional hazards regression was used to determine the independent significant factors for disease-specific survival (DSS).

Results: Twenty-four (51.1%) of 47 patients and 3 (60%) of 5 patients showed symptom improvement after radiotherapy or surgery, respectively. The number of involved vertebrae (1 or 2) as well as ambulatory and Eastern Cooperative Oncology Group performance status (ECOG PS, 1 or 2) before radiotherapy or surgery were significant predictors of improvement of symptoms caused by MSCC (p=0.024, p=0.001, and p=0.001, respectively). In the multivariate analysis, hemoglobin (¡Ã11.1), the number of involved vertebrae (1 or 2), and ECOG PS (1 or 2) remained significant predictors (p=0.021, p=0.033, and p=0.034, respectively). On the Kaplan-Meier curve, however, only ECOG PS (1 or 2) was a significant factor predicting DSS (p=0.014).

Conclusions: In our study, improvement of symptoms after treatment was observed in half of the MSCC patients; however, there were no factors predicting symptom improvement other than the number of involved vertebrae and the patients¡¯ ambulatory and performance status at the time of treatment. Patients with ECOG PS 1 or 2 may therefore be expected to have good DSS after radiotherapy or surgery.

Å°¿öµå

Prostatic neoplasms;Spinal cord compression;Radiotherapy;Survival rate

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS